The Drug Enforcement Administration is proposing to remove naloxegol from all Controlled Substances Act schedules, according to an Oct. 29 Federal Register notice (79 Fed. Reg. 64349). Naloxegol, also referred to as PEG-naloxol, is a new molecular entity derived from naloxone, a Schedule II substance. On Sept. 16, the U.S. Food and Drug Administration approved a new drug applicati... Read More